Pioderma gangrenoso y fístulas enterocutáneas tras anastomosis ileoanal con reservorioGangrenous pyoderma and enterocutaneous fistulas after ileal. Introducción: la baja prevalencia de las fístulas enterocutáneas (FEC) en los pacientes con enfermedad de Crohn (EC) justifica la escasez de. Necesidad de formar unidades funcionales especializadas en el manejo médico- quirúrgico de pacientes con fístulas enterocutáneas y fracaso intestinal.

Author: Kajiktilar Nehn
Country: Luxembourg
Language: English (Spanish)
Genre: Finance
Published (Last): 11 August 2012
Pages: 179
PDF File Size: 7.90 Mb
ePub File Size: 7.99 Mb
ISBN: 849-4-98687-863-3
Downloads: 34330
Price: Free* [*Free Regsitration Required]
Uploader: Zulkit

In this series, as in others [24], sepsis, multiple lesions and abdominal wall defects have been statistically significant mortality factors. In particular after multiple laparotomies for severe intraabdominal infection, awaiting consolidation and the formation of neoperitoneum seems comprehensible. Diagnosis was made after physical examination and a computed tomography CT or magnetic resonance MRI study.

Fistulas – Fistulas Enterocutaneas – Dr. Daniel Wainstein

In our series, the mean time from the diagnosis of CD to the onset of ECF was months, meaning we have to assume that the type of treatment to be used will depend on the factors mentioned above. Variables were faced with the mortality event using program SPSS version Discussion ECF rarely responds to fistjlas treatment and a high percentage of patients ultimately require surgical treatment Nevertheless, if it appears later but within 60 days, a watchful approach with enteral or parenteral nutrition may be taken given that these usually close if there is no associated obstructive component.


They were treated with antibiotics, immunosuppressants and even surgery. Adalimumab – an effective and promising treatment for patients with fistulizing Crohn’s disease: If the fistula is postoperative and occurs within the first 7 days, re-do surgery will be required. ECF rarely responds to medical treatment and a high percentage of patients ultimately require enterocutanfas treatment In recent years, advances in postoperative care and major surgical procedures rise have further increased the degree of complexity and the number of cases, which justifies further study of this pathology.

While it is true that fisrulas patients require frequent decision-taking during treatment, surgery as initial indication is a major issue.

The appearance of postoperative enterocutaneous fistula makes a deep trouble for the patient, a high concern to the surgeon and major economic costs for the institutions. Treatment The following treatments were considered: The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: Sepsis, multiple lesions and abdominal wall defect were negatives prognoses factors. Initial surgery is a valid option in patients maintaining a good general condition and is a necessity in cases where the fistula coexists with acute abdomen.

For a long time, it has been convention to wait 4 and 6 weeks for a spontaneous resolution and then, in case of persistence, to proceed with reconstructive surgery [1].

J Am Coll Surg ; 4: The data are very limited and consist primarily of small case series. Int J Colorectal Dis ; J Clin Gastroenterol 2 These data may be explained by the fact that ECF has a pathophysiology distinct from perianal fistulas.

There was a problem providing the content you requested

Am J Gastroenterol ; But, low habituallity in management of said complication generates doubts at time to choose the more suitable therapeutic strategy, which can hit negatively in the final result of the treatment. The indication for surgery, the response or lack thereof to treatment of both the disease and the ECF, as well as the correlation between one and the other was evaluated in all patients.


University of Buenos Aires. Global healing was possible in patients of the series Nevertheless, enrerocutaneas has not been shown that gastrointestinal secretion and volume overload reduction on the fistula increases the possibility of spontaneous closure [10]. Infliximab as a therapy for non-Crohn’s enterocutaneous fistulae.

Lastly, 49 patients Management were performed using an own protocol, in accordance with Chapman’s Stages [2], which have been already presented in previous publications [1]. Management of external small bowel fistulae: Both EN enterodutaneas PN are resources that the specialist team should handle so as to indicate them, either in combination or alternatively, according to the case nature.

A Systematic review of the benefit of fixtulas parenteral nutrition in the management of enterocutaneous fistulas. Spontaneous enterocutaneous fistulas ECF originate in the ileum and are open to the skin of the abdominal wall.